Table 1.
Primary sites | Associated diseases | |||
---|---|---|---|---|
Malignant tumors | Benign tumors | Inflammatory tumors | All | |
n (%) | n (%) | n (%) | n (%) | |
Breast | 14 (20.3) | 2 (2.9) | 1 (1.4) | 17 (24.6) |
Node | 6 (8.7)∗ | 2 (2.9) | 4 (5.8) | 12 (17.4) |
Liver | 6 (8.7) | — | — | 6 (8.7) |
Cervix uteri | 5 (7.2) | 1 (1.4) | 2 (2.9) | 8 (11.5) |
Eyes | 4 (5.8) | 2 (2.8) | — | 5 (7.2) |
Skin | 4 (5.8) | — | — | 4 (5.8) |
Soft tissues | 3 (4.3) | — | — | 3 (4.3) |
Eyelids | 2 (2.9) | — | — | 2 (2.9) |
Lung | 2 (2.9) | — | — | 2 (2.9) |
Colon | 2 (2.9) | — | — | 2 (2.9) |
Pancreas | 1 (1.4) | — | — | 1 (1.4) |
Bone | 1 (1.4) | — | — | 1 (1.4) |
Bladder | 1 (1.4) | — | — | 1 (1.4) |
Larynx | 1 (1.4) | — | — | 1 (1.4) |
Kidney | — | 1 (1.4) | — | 1 (1.4) |
Unknown | 2 (2.8) | — | — | 2 (2.9) |
All | 54 (78.3) | 8 (11.6) | 7 (10.1) | 69 (100) |
∗Non-Hodgkin lymphoma.